Alliance Pharma plc (APH) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.099x

Based on the latest financial reports, Alliance Pharma plc (APH) has a cash flow conversion efficiency ratio of 0.099x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX20.47 Million ≈ $2.49K USD) by net assets (GBX207.64 Million ≈ $25.26K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Alliance Pharma plc - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Alliance Pharma plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Alliance Pharma plc (APH) financial obligations for a breakdown of total debt and financial obligations.

Alliance Pharma plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alliance Pharma plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Horus AG
STU:HRU
N/A
CASI Pharmaceuticals Inc
NASDAQ:CASI
0.029x
Vault Strategic Mining Corp.
V:KNOX
0.054x
NEX Metals Exploration Ltd
AU:NME
0.158x
Dermata Therapeutics Inc
NASDAQ:DRMA
-0.455x
Yunnan Water Investment Co. Limited
F:2WI
-0.010x
Altur Slatina
RO:ALT
N/A
PREMIER AFRICAN MINERALS
F:0PA
N/A

Annual Cash Flow Conversion Efficiency for Alliance Pharma plc (1999–2024)

The table below shows the annual cash flow conversion efficiency of Alliance Pharma plc from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see Alliance Pharma plc (APH) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX207.64 Million
≈ $25.26K
GBX38.72 Million
≈ $4.71K
0.186x +29.33%
2023-12-31 GBX217.87 Million
≈ $26.51K
GBX31.41 Million
≈ $3.82K
0.144x +97.75%
2022-12-31 GBX287.66 Million
≈ $35.00K
GBX20.97 Million
≈ $2.55K
0.073x -46.73%
2021-12-31 GBX282.49 Million
≈ $34.37K
GBX38.66 Million
≈ $4.70K
0.137x -7.50%
2020-12-31 GBX280.96 Million
≈ $34.18K
GBX41.57 Million
≈ $5.06K
0.148x +13.44%
2019-12-31 GBX274.18 Million
≈ $33.36K
GBX35.76 Million
≈ $4.35K
0.130x +48.36%
2018-12-31 GBX252.20 Million
≈ $30.69K
GBX22.17 Million
≈ $2.70K
0.088x -32.75%
2017-12-31 GBX203.38 Million
≈ $24.75K
GBX26.58 Million
≈ $3.23K
0.131x +38.44%
2016-12-31 GBX179.26 Million
≈ $21.81K
GBX16.93 Million
≈ $2.06K
0.094x +92.29%
2015-12-31 GBX162.44 Million
≈ $19.76K
GBX7.98 Million
≈ $970.45
0.049x -69.58%
2014-12-31 GBX70.78 Million
≈ $8.61K
GBX11.42 Million
≈ $1.39K
0.161x +4.05%
2013-12-31 GBX64.67 Million
≈ $7.87K
GBX10.03 Million
≈ $1.22K
0.155x -35.33%
2012-12-31 GBX51.85 Million
≈ $6.31K
GBX12.44 Million
≈ $1.51K
0.240x +21.38%
2011-12-31 GBX44.13 Million
≈ $5.37K
GBX8.72 Million
≈ $1.06K
0.198x -52.14%
2010-12-31 GBX36.08 Million
≈ $4.39K
GBX14.89 Million
≈ $1.81K
0.413x -10.77%
2009-12-31 GBX16.63 Million
≈ $2.02K
GBX7.69 Million
≈ $936.14
0.463x +55.02%
2008-12-31 GBX8.77 Million
≈ $1.07K
GBX2.62 Million
≈ $318.29
0.298x +16.83%
2007-12-31 GBX6.67 Million
≈ $811.06
GBX1.70 Million
≈ $207.21
0.255x +392.87%
2006-12-31 GBX10.43 Million
≈ $1.27K
GBX-910.00K
≈ $-110.72
-0.087x -281.83%
2005-12-31 GBX7.50 Million
≈ $913.02
GBX360.00K
≈ $43.80
0.048x +229.42%
2005-02-28 GBX6.83 Million
≈ $830.41
GBX-253.00K
≈ $-30.78
-0.037x +93.01%
2004-02-29 GBX2.23 Million
≈ $270.72
GBX-1.18 Million
≈ $-143.57
-0.530x +89.46%
2003-02-28 GBX-194.00K
≈ $-23.60
GBX976.00K
≈ $118.75
-5.031x -13921.47%
2002-12-31 GBX2.24 Million
≈ $272.16
GBX-80.26K
≈ $-9.77
-0.036x +97.21%
2002-02-28 GBX538.00K
≈ $65.46
GBX-692.00K
≈ $-84.20
-1.286x -3926.58%
2001-02-28 GBX595.00K
≈ $72.39
GBX20.00K
≈ $2.43
0.034x -95.49%
2000-02-29 GBX451.00K
≈ $54.87
GBX336.00K
≈ $40.88
0.745x -93.85%
1999-02-28 GBX114.00K
≈ $13.87
GBX1.38 Million
≈ $168.03
12.114x --

About Alliance Pharma plc

LSE:APH UK Drug Manufacturers - Specialty & Generic
Market Cap
$4.26 Million
GBX34.97 Billion GBX
Market Cap Rank
#28657 Global
#505 in UK
Share Price
GBX64.70
Change (1 day)
+0.00%
52-Week Range
GBX64.50 - GBX64.70
All Time High
GBX116.47
About

Alliance Pharma plc, a holding company, acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names. The company was incorporated i… Read more